162 related articles for article (PubMed ID: 24995714)
1. Serum biomarkers for detection of head and neck squamous cell carcinoma.
Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA
Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714
[TBL] [Abstract][Full Text] [Related]
2. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
3. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
[TBL] [Abstract][Full Text] [Related]
4. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
6. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
7. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
8. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation in Indian primary oral squamous cell carcinoma.
Kaur J; Demokan S; Tripathi SC; Macha MA; Begum S; Califano JA; Ralhan R
Int J Cancer; 2010 Nov; 127(10):2367-73. PubMed ID: 20473870
[TBL] [Abstract][Full Text] [Related]
10. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
11. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
13. Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.
Hayashi M; Guerrero-Preston R; Okamura J; Michailidi C; Kahn Z; Li X; Ahn J; Goldsmith M; Koch W
Ann Surg Oncol; 2014 Sep; 21(9):3124-31. PubMed ID: 24671639
[TBL] [Abstract][Full Text] [Related]
14. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
[TBL] [Abstract][Full Text] [Related]
15. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.
Roh JL; Wang XV; Manola J; Sidransky D; Forastiere AA; Koch WM
Clin Cancer Res; 2013 May; 19(9):2528-40. PubMed ID: 23444219
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
[TBL] [Abstract][Full Text] [Related]
19. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]